XORTX Therapeutics (XRTX) Stock Skyrockets on Kidney Drug Deal – Key Facts & Outlook
Shares of XORTX Therapeutics Inc. surged on October 17, 2025 after the nano-cap biotech announced a strategic acquisition in its core therapeutic area. The stock rocketed up immediately following the morning press release, spiking up to 40% in early trading. By midday, XRTX was changing hands at just over $1.20 per shareragingbull.com. It eventually closed about 21% higher on Fridaytipranks.com – a dramatic move for a company that had been trading quietly near the $1 level.
